NCT06721065

A Study of Language Interpretation Solutions for People With Breast Cancer

RSMI HEALS (Health Equity Advances Through Language Solutions) (AI)

• Status: Recruiting
• Phase: N/A
• Study type: Interventional
• Enrollment: 700 (estimated)
• Sponsor: Memorial Sloan Kettering Cancer Center · Academic / Other
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

The study will be conducted in 2 overlapping phases. In Phase 1, there will be a 3-arm randomized controlled trial of Remote Simultaneous Medical Interpreting/RSMI (Arm 1), versus Remote Consecutive Medical Interpreting/RCMI (Arm 2) and versus Remote Consecutive Video Medical Interpreting/RCVI (Arm 3) in breast cancer outpatient clinical encounters with Spanish- and Mandarin-speaking patients with Limited English Proficiency/LEP (Stages II and III disease) and English- speaking providers (who do not speak Spanish/Mandarin). In Phase 2, there will be a sequential mixed-methods explanatory, multi-stakeholder process evaluation to gather implementation potential data.

Conditions

• Breast Cancer
• Breast Cancer Stage II
• Breast Cancer Stage III

Interventions

Type	Name	Description
OTHER	Remote Simultaneous Medical Interpreting/RSMI	Remote Simultaneous Medical Interpreting (RSMI), "UN-style" simultaneous interpreting applied to the medical encounter, which holds tremendous promise for closely approximating a same language encounter, decreasing interpreting errors, and improving outcomes.
OTHER	Remote Consecutive Medical Interpreting/RCMI	Remote Consecutive Medical Interpreting (RCMI; "audio consecutive"), is the most commonly utilized remote interpreting
OTHER	Remote Consecutive Video Medical Interpreting/RCVI	Remote Simultaneous Medical Interpreting (RSMI), "UN-style" simultaneous interpreting applied to the medical encounter

Timeline

• Start date: 2024-12-02
• Primary completion: 2029-12-02
• Completion: 2029-12-02
• First posted: 2024-12-06
• Last updated: 2026-04-02

Locations

8 sites across 1 country: United States